Non-alcoholic fatty liver disease: epidemiology, pathophysiology, diagnosis and treatment

Paediatrics and Child Health

Volumn 20, Issue 1, 2010, Pages 26-29

  Yu, Elizabeth L ^a   Schwimmer, Jeffrey B ^a   Lavine, Joel E ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

fatty liver; NASH; nonalcoholic fatty liver disease; obesity

Indexed keywords

ALPHA TOCOPHEROL; METFORMIN;

CLINICAL TRIAL; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ECHOGRAPHY; ETHNICITY; FATTY LIVER; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW;

EID: 73649140634     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2009.09.005     Document Type: Review

References (15)

1. N.J. Barshop C.B. Sirlin J.B. Schwimmer J.E. Lavine Epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease Aliment Pharmacol Ther 28 2008 13 24
2. S. Chitturi S. Abeygunasekera G.C. Farrell NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373 379
3. M.M. Davis V. Gance-Cleveland S. Hassick R. Johnson G. Paradis K. Resnicow Recommendations for prevention of childhood obesity Pediatrics 120 2007 S229 S253
4. C.P. Day O.F. James Steatohepatitis: a tale of two ‘hits’? Gastroenterology 114 1998 842 845
5. K.L. Donnelly C.I. Smith S.J. Schwarzenberg J. Jessurun M.D. Boldt E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
6. J.E. Lavine J.B. Schwimmer Nonalcoholic fatty liver disease in the pediatric population Clin Liver Dis 8 2004 549 558
7. M.H. Patton C. Sirlin C. Behling M. Middleton J.B. Schwimmer J.E. Lavine Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research J Pediatr Gastroenterol Nutr 43 2006 413 427
8. H.M. Patton J.E. Lavine M.L. Van Natta J.B. Schwimmer D. Kleiner J. Molleston Clinical correlates of histopathology in pediatric non-alcoholic steatohepatitis Gastroenterology 135 2008 1961 1971
9. E.A. Roberts Non-alcoholic steatohepatitis in children Clin Liver Dis 11 2007 155 172
10. J.B. Schwimmer P.E. Pardee J.E. Lavine A.K. Blumkin S. Cook Cardiovascular risk factors and the metabolic syndrome in pediatric non-alcoholic fatty liver disease Circulation 118 2008 273 283
11. J.B. Schwimmer C. Behling R. Newbury Histopathology of pediatric non-alcoholic fatty liver disease Hepatology 42 2005 641 649
12. J.B. Schwimmer R. Deutsh T. Kahen J.E. Lavine C. Stanley C. Behling Prevalence of fatty liver in children and adolescents Pediatrics 118 2006 1388 1393
13. J.B. Schwimmer M.S. Middleton J.E. Lavine A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis Aliment Pharmacol Ther 21 2005 871 879
14. J.B. Schwimmer N. McGreal R. Deutsh M.J. Finegold J.E. Lavine Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents Pediatrics 115 2005 561 565
15. D. Van der Poorten K.L. Milner J. Hui Visceral fat: a key mediator of steatohepatitis in metabolic liver disease Hepatology 48 2008 449 457